Skip to content

Neogen NEOG Investing Cash Flow

Investing Cash Flow at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
-$8.96B-1,600%
Idexx Laboratories logo
Idexx LaboratoriesIDXX
-$33.54M-13.3%
Zoetis logo
ZoetisZTS
-$87M+57.1%
Revvity logo
RevvityRVTY
-$78.27M-1,127%
Agilent Technologies logo
Agilent TechnologiesA
-$77M+32.5%
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
-$93.2M-3,314%

Other financials

Income statement

See full
Revenue$211.2M-4.4%
Gross profit$99.0M-10.2%
Operating income-$3.3M-161%
Net income-$17.0M-56.0%
EPS (diluted)-$0.08-60.0%

Balance sheet

See full
Cash & equivalents$159.9M+25.2%
Total debt$793.3M-11.2%
Total equity$2.1B-21.0%
Total assets$3.4B-16.8%

Cash flow

See full
Operating cash flow$22.7M+16.7%
CapEx$11.6M-64.7%
Free cash flow$11.1M+182%

Valuation

See full
Market cap$2B+93.1%
Enterprise value$2.63B+45.5%
P/S2.3×+1.1×

Profitability

See full
Gross margin45.2%-3.6pp
Operating margin-73.1%+77.7pp
Net margin-69.9%+30.8pp
FCF margin-14%

Returns & leverage

See full
Return on equity-25.6%+28.8pp
Debt / equity0.4×0.0×
Current ratio3.9×0.0×

Where this comes from

Reported directly by Neogen in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.

The official record: Neogen’s 10-Q, filed October 9, 2025, on SEC EDGAR. View the filing →

Ask your AI about Neogen's investing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Neogen's investing cash flow?
Neogen (NEOG) reported investing cash flow of $97.73M in Q2 2025.
How has Neogen's investing cash flow changed year-over-year?
Neogen's investing cash flow increased by 390.3% year-over-year, from -$33.66M to $97.73M.
What is the long-term trend for Neogen's investing cash flow?
Over 4 years (2021 to 2025), Neogen's investing cash flow has grown at a -10.5% compound annual growth rate (CAGR), from -$154.75M to -$99.2M.
What does investing cash flow mean?
Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.